Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by 2027

1. Nuclear Medicine/Radiopharmaceuticals Market -Size, Business Analysis and Growth Rate Report In the report,Nuclear Medicine/Radiopharmaceuticals Market has been analyzed through a segmental perspective. The market segmentation allows a deeper understanding of the market hotspots. Global Nuclear Medicine/Radiopharmaceuticals Market was valued at USD 6.5 billion in 2019 which is expected to reach USD 12.25 billion by 2027 at a CAGR 9.88%. Nuclear medicines/radiopharmaceuticals are radioactive compounds which are administered to patients and monitored via special imaging devices. These are used to diagnosis and therapeutic purposes. Nuclear medicines or radiopharmaceutical components are composed of organic molecules with radioisotopes. Radioisotopes emits gamma rays are used for diagnosis. Request Sample Copy of this Report @ https://qualiketresearch.com/request-sample/Nuclear- MedicineRadiopharmaceuticals-Market/request-sample Market Drivers Increase in incidences of chronic diseases like cancer is the key driving factor which is expected to boost the global nuclear medicine/ radiopharmaceuticals market growth. For instance, in 2018, according to World Health Organization (WHO) around 9.6 million people were dead due to cancer

2. across the world. Also, increase in prevalence of cardiovascular diseases will have the positive impact on global nuclear medicine/ radiopharmaceuticals market growth. Furthermore, increase in technological advancements is expected to propel the global nuclear medicine/ radiopharmaceuticals market growth. Market Restraints However, short life of radiopharmaceuticals is the restraining factor for market which is expected to hamper the global nuclear/ radiopharmaceuticals market growth. Also, logistical difficulties, supply shortage and lack of qualified professionals will affect the global nuclear medicine/ radiopharmaceuticals market growth. Market Key Players Various key players are discussed in this report such as Iba Molecular, Advanced Accelerator Applications S.A., Nordion, Inc, Eczacibasi-Monrol Nuclear Products, Bracco Imaging S.P.A, Bayer AG, Lantheus Medical Imaging, Inc., GE Healthcare, Mallinckrodt PLC, and Cardinal Health, Inc. Market Taxonomy By Type Diagnostic Nuclear Medicine oSPECT Radiopharmaceuticals oTc-99m oTl-201 oGa-67 oOthers PET Radiopharmaceuticals oF-18 oRubidium-82 oOthers By Procedure

3. Brachytherapy Isotopes Alpha Emitters Beta Emitters Therapeutic Procedures PET Radiopharmaceuticals SPECT Radiopharmaceuticals By Application Cardiology Oncology Neurology Thyroid Others By Region North America Latin America Asia Pacific Europe Middle East & Africa Get discount on this report @ https://qualiketresearch.com/request-sample/Nuclear- MedicineRadiopharmaceuticals-Market/ask-for-discount

4. Get in touch QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. Contact Person: Vishal Thakur Research Support Specialist QualiKet Research 6060 N Central Expy #500, TX 75204, U.S.A sales@qualiketresearch.com Website: https://qualiketresearch.com